There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CPC C07D401/14
Pages in category "CPC C07D401/14"
The following 124 pages are in this category, out of 124 total.
1
- 18287586. COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES simplified abstract (The Regents of the University of California)
- 18532636. TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18532671. TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN simplified abstract (The Regents of the University of California)
- 18580986. COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES (Novartis AG)
- 18786228. PARP7 INHIBITORS (Gilead Sciences, Inc.)
- 18829547. METHODS AND INTERMEDIATES FOR PREPARING THERAPEUTIC COMPOUNDS (Gilead Sciences, Inc.)
- 18832887. SYNTHESIS OF A KIF18A INHIBITOR (AMGEN INC.)
2
- 20250154126. Crys (JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.)
- 20250154127. Bicyclic (ETERN BIOPHARMA (SHANGHAI) CO., LTD.)
- 20250163024. Chemical Ta (Dana-Farber Cancer Institute, .)
- 20250163025. Compounds (Bristol-Myers Squibb)
- 20250171416. Novel Pyrimidine-2,4-diamine Derivatives, Preparation Method Therefor, Pharmaceutical Composition Containing Same As Active Ingredient Pr (KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY)
- 20250171417. Heteroc (Xizang Haisco Pharmaceutical ., .)
- 20250171418. Parp1 Inhibitors Uses There (XinThera, .)
- 20250171419. Novel Nicotina (Heidelberg Pharma Research)
- 20250171420. Molecular Glue D (Monte Rosa Therapeutics, .)
- 20250188056. Cereblon Binding Compounds (Celgene)
- 20250188057. Non-aromatic Cyclic-py (Merck Sharp & Dohme LLC)
- 20250188058. New Forms N-(5-((6,7-dime (QURIENT ., .)
- 20250188059. Novel Compound Use T (ARUM THERAPEUTICS)
- 20250206717. Compound Havin (Innovstone Therapeutics Limited)
- 20250206718. Nitrogen- (SHANGHAI HANSOH BIOMEDICAL ., .)
- 20250206719. Albicidin Deriv (TECHNISCHE UNIVERSITÄT BERLIN)
- 20250206720. Solid Forms (Deciphera Pharmaceuticals, LLC)
- 20250206721. Prostaglandin Receptor Ep2 (EMORY UNIVERSITY)
- 20250214965. Compound As (Hangzhou Innogate Pharma ., .)
- 20250214966. Crystalline Salt Form (Array BioPharma .)
- 20250214967. Fak Degraders, Pha (Berrybio (Shanghai) Limited)
- 20250214968. Novel Salt (Ildong Pharmaceutical ., .)
- 20250214969. Protein Degraders (Kymera Therapeutics, .)
- 20250214970. Pyridinylacetamide (Xenon Pharmaceuticals .)
- 20250214971. Quaternary I (Corcept Therapeutics Incorporated)
- 20250214972. Five (HANGZHOU POLYMED BIOPHARMACEUTICALS, .)
- 20250230140. Novel (Viva Star Biosciences (Suzhou) ., .)
- 20250230141. Substituted Fused Bicyclic Comp (Alkermes, .)
- 20250230142. Substituted Fused Bicyclic Comp (Alkermes, .)
- 20250230143. Phthalazine Deriva (Sitryx Therapeutics Limited)
- 20250230144. Quinazolines As P (Bristol-Myers Squibb)
A
- AbbVie Inc. Patent Application Trends in 2025
- ACLARIS THERAPEUTICS, INC. Patent Application Trends in 2024
- Amgen Inc. Patent Application Trends in 2024
- ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA Patent Application Trends in 2024
- ASTELLAS PHARMA INC. Patent Application Trends in 2024
- AstraZeneca AB Patent Application Trends in 2024
- AstraZeneca AB Patent Application Trends in 2025
- Athos Therapeutics, Inc. Patent Application Trends in 2024
B
- BASF SE Patent Application Trends in 2025
- Bayer Aktiengesellschaft Patent Application Trends in 2025
- BioTheryX, Inc. Patent Application Trends in 2024
- Blueprint Medicines Corporation Patent Application Trends in 2024
- Board of Regents, The University of Texas System Patent Application Trends in 2024
- BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM Patent Application Trends in 2024
- Boehringer Ingelheim International GmbH Patent Application Trends in 2025
- BRISTOL-MYERS SQUIBB COMPANY Patent Application Trends in 2024
- BRISTOL-MYERS SQUIBB COMPANY Patent Application Trends in 2025
C
D
- Dana-Farber Cancer Institute, Inc. Patent Application Trends in 2024
- Dana-Farber Cancer Institute, Inc. Patent Application Trends in 2025
- DANA-FARBER CANCER INSTITUTE, INC. Patent Application Trends in 2025
- Deciphera Pharmaceuticals, LLC Patent Application Trends in 2024
- Deciphera Pharmaceuticals, LLC Patent Application Trends in 2025
F
G
H
I
J
K
L
M
N
- NANJING NUOYUAN MEDICAL INSTRUMENT CO.LTD Patent Application Trends in 2025
- NeuPharma, Inc Patent Application Trends in 2024
- New York University Patent Application Trends in 2025
- NEW YORK UNIVERSITY Patent Application Trends in 2025
- Nimbus Saturn, Inc. Patent Application Trends in 2024
- Northwestern University Patent Application Trends in 2025
- NOVARTIS AG Patent Application Trends in 2025
- Novartis AG Patent Application Trends in 2025
P
R
- Regents of the University of Minnesota Patent Application Trends in 2024
- REGENTS OF THE UNIVERSITY OF MINNESOTA Patent Application Trends in 2024
- Revolution Medicines, Inc. Patent Application Trends in 2024
- RHIZEN PHARMACEUTICALS AG Patent Application Trends in 2024
- ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. Patent Application Trends in 2024
S
T
- TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent Application Trends in 2024
- TEVA CZECH INDUSTRIES S.R.O Patent Application Trends in 2024
- The Board of Trustees of the Leland Stanford Junior University Patent Application Trends in 2024
- The General Hospital Corporation Patent Application Trends in 2025
- The Hong Kong Polytechnic University Patent Application Trends in 2024
- The Regents of The University Of California Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Patent Application Trends in 2024
- The Regents of the University of California Patent Application Trends in 2025
- The Regents of The University Of California Patent Application Trends in 2025
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2024
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN Patent Application Trends in 2025
- The Regents of the University of Michigan Patent Application Trends in 2025
- The U.S.A., as represented by the Secretary, Department of Health and Human Services Patent Application Trends in 2025